This ticker has not been starred yet TECH Bio-Techne Corp
Biological Products (no Diagnostic Substances)
Book value per $ invested $ 0.25
Leverage 20.28%
Market Cap $ 8.2B
PE 99.93
Dividend Yield 0.62%
Profit $ 81.8m
Margin 6.74%

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.

Subscribe Now For Access - Only $1.99 Per Month